David A. Dodd, Chairman and CEO of GeoVax Labs, Inc., shares updates on the company’s capital strategy, vaccine and cancer therapy programs, and upcoming pivotal clinical trials.
February 7, 2023
David A. Dodd, Chairman and CEO of GeoVax Labs, Inc., shares updates on the company’s capital strategy, vaccine and cancer therapy programs, and upcoming pivotal clinical trials.
Other Interviews
